Intracellular Signaling

Cell signaling (cell signalling in British English) is part of any communication process that governs basic activities of cells and coordinates all cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated more effectively and, theoretically, artificial tissues may be created.

Intracellular Signaling Products Targets

Products for Intracellular Signaling - Page 60

  1. Cat.No. Product Name Information/Activity
  2. BCC6828 Palmitoylethanolamide Impulsin (AM 3112) is an active endogenous compound which can used for preventing virus infection of the respiratory tract. Palmitoylethanolamide chemical structure
  3. BCC2265 WY-14643 (Pirinixic Acid) Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively. WY-14643 (Pirinixic Acid) chemical structure
  4. BCC7017 MK 886 MK886 is a potent 5-lipoxygenase activating protein inhibitor (FLAP) also a non-competitive inhibitor of PPAR alpha. a potent inhibitor of leukotriene (LT) biosynthesis in intact human polymorphonuclear leukocytes with IC 50 of 2.5 nM. Block the synthessis of leukotrien intact activate leukocyte. MK 886 chemical structure
  5. BCC2267 GW0742 GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively. GW0742 chemical structure
  6. BCC2268 GW501516 GW 501516 is a PPARδ agonist with an EC50 of 1.1 nM. GW501516 chemical structure
  7. BCC1573 FH535 FH535 is an inhibitor of Wnt/β-catenin and PPAR, with anti-tumor activities. FH535 chemical structure
  8. BCC7688 GSK 0660 GSK0660 is a potent antagonist of PPARβ and PPARδ, with IC50s of 155 nM for both isoforms. GSK 0660 chemical structure
  9. BCC2263 GSK3787 GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ. GSK3787 chemical structure
  10. BCC7014 Ciglitazone 74772-77-3 Ciglitazone chemical structure
  11. BCC7268 nTZDpa 118414-59-8 nTZDpa chemical structure

Items 591 to 600 of 659 total